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Introduction
AMP-activated protein kinase (AMPK) is a serine/threonine 
kinase and a prominent metabolic sensor in cells. At the cellu-
lar level, energy stress leads to the activation of AMPK, which 
inhibits energy-consuming anabolic pathways and triggers en-
ergy-promoting catabolic pathways (Hardie et al., 2012). Be-
cause of the critical role of AMPK in metabolic regulation, 
this kinase has become an attractive therapeutic target for 
the treatment of obesity, diabetes, and cancer (Hardie, 2013). 
Apart from its well-described role in maintaining cellular en-
ergy homeostasis, AMPK regulates several other physiological 
processes, including cell growth, autophagy, cell polarity, de-
velopment, mitosis, and transcription (Zhang et al., 2006; Lee 
et al., 2007; Nakano et al., 2010; Banko et al., 2011; Mihaylova 
and Shaw, 2011; Schaffer et al., 2015). In a screen performed 
recently in human cancer cell lines, many newly identified 
AMPK substrates consisted of proteins involved in cell motil-
ity, adhesion, and invasion (Schaffer et al., 2015). Nevertheless, 
the role of AMPK in cell adhesion and mechanotransduction 
remains largely underexplored.
Integrins are transmembrane receptors that mediate cell–
matrix interactions, with key functions in cell adhesion, mi-
gration, and mechanotransduction. Integrins are heterodimers, 
consisting of an α and a β subunit, and exist at the plasma mem-
brane in either the bent (inactive) conformation or the extended 
(active) conformation (Hynes, 2002). Integrin binding to ECM 
ligands promotes conformational changes within the receptor 
that favor integrin activation in a process called outside-in sig-
naling. Alternatively, several proteins bound to the intracellular 
part of integrins regulate receptor conformation and thus activ-
ity via so-called inside-out activation (Kim et al., 2011). Talins 
and kindlins are both well-described integrin activators, which 
bind the cytoplasmic tail of β-integrins (Calderwood et al., 
2013). Conversely, other proteins, such as SHA RPIN, DOK-1, 
ICAP1, and filamin, inhibit integrin activation by directly or in-
directly disrupting the integrin–talin interaction (Bouvard et al., 
2013). One family of proteins, known as tensins, bind integrins 
at a region overlapping with the talin-binding site (McCleverty 
et al., 2007), yet the role of this family in influencing integrin 
inside-out activation has not been investigated.
We found that the major metabolic sensor AMPK is an 
inhibitor of β1-integrin activity. Loss of AMPK promotes 
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integrin activity and the formation of mature fibrillar adhesions 
with high levels of active α5β1-integrin and tensin. We further 
show that tensins can activate integrins and that AMPK inhibits 
β1-integrin activity by negatively regulating tensin levels. Con-
gruently, AMPK-mediated inhibition of cell spreading, traction 
stress, and ECM assembly are tensin dependent.
Results
AMPK negatively regulates β1-
integrin activity
AMPK is a heterotrimeric protein complex consisting of the 
catalytic α subunit and the regulatory β and γ subunits with at 
least two isoforms each (α1, α2; β1, β2; γ1, γ2, γ3; Hardie et 
al., 2012). Based on quantitative proteomic analyses, AMPK 
is a component of the fibronectin-induced integrin adhesome, 
as different subunits were identified in three independent mass 
spectrometry–based proteomics datasets (Schiller et al., 2013; 
Horton et al., 2015; Robertson et al., 2015). Moreover, AMPK 
is a putative β1-integrin inactivator. Indeed, in the kinome 
RNAi screen we performed previously (Rantala et al., 2011), 
two independent siRNAs against PRK AA2 (AMPKα2) and one 
of two siRNAs targeting the AMPK regulatory β subunit PRK 
AB2 (AMPKβ2) significantly increased β1-integrin activity. 
Interestingly, the regulatory γ subunit (AMPKγ2) is also asso-
ciated with integrin activity, as it was identified as a putative 
integrin inhibitor in the druggable genomewide RNAi screen 
we performed in prostate cancer cells (VCap; Pellinen et al., 
2012) and as a potential adhesome component associated with 
inactive β1-integrins (Byron et al., 2015).
To validate the role of AMPK in integrin activity sug-
gested by these unbiased screens, we used immortalized mouse 
embryonic fibroblasts (MEFs) with wild-type (WT) AMPKα 
(α1+/−;α2+/+) or with nullizygous AMPKα1 (α1−/−;α2+/+ or 
α1-knockout [KO; α1KO]), AMPKα2 (α1+/−;α2−/− or α2KO), 
or both (α1−/−;α2−/− or KO), as described previously (Yan et 
al., 2015). We measured cell surface active integrins by flow 
cytometry (based on the binding of a recombinant integrin li-
gand fragment, fibronectin repeats 7–10 [FN7–10]) relative to 
total cell surface β1-integrin (Hughes et al., 2002; Tadokoro 
et al., 2003) and observed a modest increase in integrin ac-
tivity upon the loss of one AMPKα isoform (α1KO or α2KO) 
and a significant increase upon the loss of both AMPKα iso-
forms (KO) compared with WT MEFs (Figs. 1 A and S1 A). 
Silencing of the remaining second isoform in the α1KO or 
α2KO (siα2 or siα1, respectively; Figs. 1 A and S1 A) sig-
nificantly elevated integrin activity to the same extent as the 
loss of AMPKα in KO MEFs. Thus, both AMPKα isoforms 
suppress integrin activity. Consistently, loss of AMPKα in 
MEFs increased active β1-integrin levels as measured using 
the 9EG7 antibody recognizing the extended conformation 
of β1-integrin (Fig. S1 B; Byron et al., 2009; Askari et al., 
2010). AMPKα also suppressed integrin activity in human 
cells. Silencing AMPKα1 alone with two independent siRNAs 
(Fig. S1 C) or both AMPKα1 and AMPKα2 isoforms (termed 
siAMPK; Fig.  1  B) in human telomerase-immortalized fi-
broblasts (TIFs) increased integrin activity compared with 
control-silenced TIFs. Moreover, treatment with the AMPK 
inhibitor dorsomorphin (also known as Compound C) pro-
moted β1-integrin activity in TIFs (Fig.  1  C). Importantly, 
AMPK silencing significantly increased the level of and the 
adhesion area occupied by active β1-integrin compared with 
control-silenced cells as measured by high-resolution total 
internal reflection fluorescence (TIRF) microscopy (Figs. 
1 D and S1 D). AMPK silencing was nearly as efficient 
in activating β1-integrins as exogenous stimulation with 
Mn2+ (Fig. S1 E). Collectively, AMPK inhibits β1-integrin 
activity in fibroblasts.
AMPK depletion promotes fibrillar 
adhesion formation
Given the striking effect of AMPK silencing on the distri-
bution of active β1-integrin (Fig.  1  D), we assessed in more 
detail the localization of active β1-integrin in cells plated on 
fibronectin-coated crossbow-shaped micropatterns, enabling 
normalization for cell shape (Alanko et al., 2015). Represen-
tative images of individual cells (Fig. 2 A) and mean intensity 
heat maps of multiple cells addressing overall protein distribu-
tion (Chen et al., 2014b) revealed more active β1-integrin after 
AMPK deletion in centrally located adhesions in MEFs (Fig. 2, 
A and B) and in TIFs (Fig. S2 A).
In fibroblasts, integrins translocate centripetally from 
focal adhesions to mature, centrally located, elongated matrix 
contacts termed “fibrillar adhesions,” which are enriched in ac-
tive α5β1-integrin and tensin (Pankov et al., 2000; Zamir et al., 
2000). To explore whether the ability of AMPK to suppress 
integrin activity is related to fibrillar adhesion formation, we 
assessed the distribution of the active (ligand bound) α5β1- 
integrin (SNA KA51 antibody; Clark et al., 2005) and tensin1 
in spreading TIFs (because of antibody limitations, we were 
unable to study endogenous active mouse α5β1 and tensin 
in MEFs) using a high-resolution TIRF microscope. Active 
α5β1-integrin and tensin1 covered a larger cell area (Fig. 2, C 
and D), and active integrins showed a high degree of colocal-
ization with tensin1 (Fig. 2, E and F) in AMPK-silenced TIFs 
compared with controls. In contrast, the β1-integrin activator 
talin1 covered a smaller area in AMPK-silenced TIFs compared 
with control-silenced cells (Fig. S2 B). Thus, loss of AMPK 
promotes β1-integrin activity in conjunction with an increased 
formation of fibrillar adhesions.
Loss of AMPK enhances cell adhesion  
and fibrillogenesis
Integrin activation and mature matrix adhesions are associ-
ated with increased cell adhesion and spreading (Geiger and 
Yamada, 2011; Theodosiou et al., 2016). Accordingly, cell 
spreading on fibronectin, mediated predominantly by α5β1- 
and αv-integrins, was markedly enhanced in AMPK KO MEFs 
compared with WT cells and in AMPK-silenced TIFs com-
pared with control-silenced cells (Figs. 3 A and S3 A). There 
was no significant difference in the adhesion of AMPK WT 
and KO MEFs on vitronectin, the ECM ligand for αvβ3- and 
αvβ5-integrins (Fig. S3 B), suggesting that the loss of AMPK 
specifically affects the activity of β1-integrins (in this case 
α5β1-integrin). Integrin activation and fibrillar adhesions are 
also essential in ECM remodeling and fibronectin fibrillogen-
esis (Zamir et al., 2000; Gudzenko and Franz, 2015). Congru-
ently with increased fibrillar adhesions in AMPK KO MEFs, 
we observed significantly longer fibronectin fibers in AMPK 
KO MEFs supplemented with exogenous fibronectin compared 
with WT cells (Fig. 3 B). Collectively, AMPK is a negative reg-
ulator of essential integrin activity–dependent functions such 
as cell spreading and matrix remodeling.
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Loss of AMPK enhances 
mechanotransduction and 
intracellular stiffness
Fibronectin fibrillogenesis is directed by traction forces (Lem-
mon et al., 2009), and integrins represent the main mechano-
transducers of the cell (Schwarz and Gardel, 2012). Therefore, 
we sought to explore whether AMPK regulates the mechani-
cal stress exerted by MEFs on fibronectin-coated polyacryl-
amide gels using traction force microscopy. Indeed, AMPK KO 
cells generated higher traction forces compared with WT cells 
(Fig. 3 C), in accordance with a previous study showing that 
β1-integrin activation promotes the generation of cellular trac-
tion forces (Lin et al., 2013).
The mechanical properties within the cell contribute to 
cell adhesion and traction stress generation, with β1-integrin 
being a major positive mediator of the intracellular mechan-
ical state (Baker et al., 2009). We thus decided to assess the 
intracellular mechanical parameters of AMPK WT and KO 
MEFs using confocal microscopy and the recently developed 
intracellular micromanipulation technique, which measures 
Figure 1. AMPK negatively regulates β1-integrin activity. (A) Quantification of flow cytometric assays of β1-integrin activity assessed as FN7–10 binding 
relative to total β1-integrin surface (MB1.2) levels in MEFs. Data and significance are expressed relative to WT AMPK MEFs and display means ± SEM. 
10,000 cells were used per experiment. The number of independent experiments per condition (n) is represented with black dots. WT refers to MEFs ex-
pressing the catalytic AMPKα1 and AMPKα2 isoforms. α2KO and siCtrl refer to MEFs lacking the AMPKα2 catalytic subunit and silenced with control siRNA 
(P = 0.0559). α2KO and siα1 refer to MEFs lacking the AMPKα2 catalytic subunit and silenced for the remaining AMPKα1 subunit (***, P < 0.0001). 
α1KO and siCtrl refer to MEFs lacking the AMPKα1 catalytic subunit and silenced with control siRNA (***, P = 0.0009). α1KO and siα2 refer to MEFs 
lacking the AMPKα1 catalytic subunit and silenced for the remaining AMPKα2 subunit (***, P = 0.0002). KO refers to MEFs lacking both AMPKα catalytic 
isoforms (**, P = 0.0015). A two-tailed Student’s t test was used to obtain p-values. (B) Quantification of flow cytometric assays of β1-integrin activity 
assessed as FN7–10 binding relative to total β1-integrin (P5D2) in TIFs silenced with control siRNA (siCtrl) or with siRNAs against AMPKα1 and AMPKα2 
isoforms (siAMPK). Data are expressed relative to siCtrl and represent means ± SEM. 10,000 cells were used per experiment. **, P = 0.0025 (two-tailed 
Student’s t test). Below are immunoblots assessing AMPKα expression and phosphorylation levels of the AMPK target ACC (pACC). GAP DH was used as 
a loading control. (C) Quantification of flow cytometric assays of β1-integrin activity assessed as FN7–10 binding relative to total β1-integrin (P5D2) in 
TIFs treated for 24 h with 10 µM dorsomorphin (AMPK inhibitor). Data are expressed relative to control and represent means ± SEM. 10,000 cells were 
used per experiment. ***, P < 0.0001 (two-tailed Student’s t test). Below are immunoblots assessing the phosphorylation levels of pACC and total levels of 
ACC. GAP DH was used as a loading control. (D) Representative TIRF microscopy images of TIFs silenced for control (siCtrl) or AMPK (siAMPK), plated on 
fibronectin for 7 h, and stained for active β1-integrin (12G10) and F-actin (phalloidin). The level and coverage of active β1-integrin were determined and 
displayed as Tukey box plots. n > 120 cells from three biological repeats. ***, P < 0.0001 (two-tailed Student’s t test). Bar, 20 µm.
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Figure 2. AMPK depletion promotes fibrillar adhesion formation. (A and B) Representative TIRF microscopy images (A) and mean intensity maps (B) of active 
β1-integrin immunofluorescence (9EG7) in AMPK WT and KO MEFs plated on fibronectin-coated crossbow-shaped micropatterns. The level of active β1-integrin 
(blue, low level; yellow, high level) within the yellow ovals was quantified (A) and displayed as Tukey box plots. n > 25 cells from two biological repeats. The mean 
active β1-integrin distribution is represented with a heat map (B), wherein yellow corresponds to regions within the cell containing the largest accumulation of active 
β1-integrin. The white ovals indicate the centrally located adhesions. n = 20 cells. (C and D) Representative TIRF microscopy images and quantification of active 
α5β1-integrin (SNA KA51; C) and tensin1 (D) distribution in siCtrl and siAMPK TIFs plated on fibronectin for 7 h. Data are displayed as Tukey box plots. n > 70 
cells (C) and n > 180 cells (D) from three biological repeats. (A, C, and D) ***, P < 0.0001 (two-tailed Student’s t test). (E and F) Representative TIRF microscopy 
images and plot profiles of siCtrl and siAMPK TIFs plated on fibronectin for 7 h and stained for either active α5β1-integrin (SNA KA51) and tensin1 (E) or for active 
β1-integrin (12G10) and tensin1 (F). Intensity profiles of the respective molecules were obtained across the white lines in each corresponding image. Bars, 10 µm.
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the displacement of an internalized microsphere trapped in 
optical tweezers (Fig.  3  D; Guet et al., 2014; Mandal et al., 
2016). We noted significantly slower viscoelastic relaxation 
of microspheres in KO compared with WT MEFs (Fig. 3 E), 
suggesting that the microsphere microenvironment is more re-
sistant to mechanical deformation in the absence of AMPK. 
Accordingly, AMPK KO MEFs exhibited higher intracellular 
rigidity (Fig. 3 F) and a trend toward a more viscous environ-
ment compared with WT cells when curves were fitted with 
the standard linear liquid (SLL) model (see the Microrheol-
ogy in micropatterned cells section of Materials and methods; 
Fig. 3 G). However, cellular elasticity remained unaltered in the 
absence of AMPK (Fig. 3 H).
Tensin regulates integrin activity 
downstream of AMPK
Given that AMPK loss promotes the formation of tensin-rich 
fibrillar adhesions, we assessed whether AMPK could regulate 
tensin expression. Of the four tensin family members (ten-
sins1–4), tensin1 and tensin3 contain an integrin-binding (the 
phosphotyrosine-binding [PTB] domain) and an actin-binding 
site and localize to fibrillar adhesions (Clark et al., 2010). In 
Figure 3. Loss of AMPK enhances cell adhesion, 
fibrillogenesis, mechanotransduction, and intracel-
lular stiffness. (A) Adherence of AMPK WT and 
KO MEFs on fibronectin measured in real-time 
using the xCELLigence RTCA instrument. Represen-
tative curves of cell adhesion over the first 2 h and 
quantification of relative cell adhesion (cell index) 
at 2 h after plating are shown. Data are expressed 
relative to WT and represent means ± SEM. 
n = 9–11 experiments from four biological re-
peats. (B) Representative images and quantifica-
tion of fibronectin fiber length (µm) in AMPK WT 
and KO MEFs 16 h after supplementation with 10 
µg/ml fibronectin. Data are displayed as Tukey 
box plots. n > 110 fibers from three biological 
repeats. (A and B) ***, P < 0.0001 (two-tailed 
Student’s t test). (C) Representative traction force 
maps and quantification of the mean force (strain 
energy, pJ) exerted by AMPK WT and KO MEFs 
plated on fibronectin-coated (5 µg/ml) polyacryl-
amide gels with a Young’s modulus of ∼1 kPa. 
Black arrows indicate the direction of traction 
stress. Cell contours are denoted by white lines. 
The color code gives the magnitude of trac-
tion stress in Pa, which corresponds to forces of 
pN/µm2. Data are displayed as Tukey box plots. 
n = 12–14 cells from two biological repeats. 
*, P = 0.0328 (two-tailed Student’s t test). (D) Vis-
coelastic relaxation experiment in AMPK WT and 
KO MEFs. Brightfield image of a KO MEF with 
an internalized 2-µm diameter microsphere (black 
arrow) plated on a crossbow-shaped micropattern 
(dotted lines). The schematic depicts the principle 
of the experiment. The bead is initially trapped 
using optical tweezers. A step displacement (Xs = 
0.5 µm) is then applied to the cell. The displace-
ment of the bead xb(t) relative to the fixed position 
of the optical trap is measured. (B–D) Bars: (B) 20 
µm; (C and D) 10 µm. (E) Averaged relaxation 
curves of the bead position after the 0.5-µm step 
in AMPK WT and KO MEFs. (F–H) Mean values of 
the rigidity index (F) and of the rheological param-
eters obtained by fitting the relaxation curves with 
a SLL model (see the Microrheology in micropat-
terned cells section of Materials and methods), the 
intracellular viscosity η (G), and the intracellular 
spring constant (H) in AMPK WT and KO MEFs. 
Data shown in E–H are from n = 24 beads from 
24 cells from three biological repeats. Error bars 
represent SEM. **, P = 0.0022 (one-tailed Stu-
dent’s t test). a.u., arbitrary units.
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AMPK KO MEFs, tensin3 protein levels were significantly in-
creased compared with WT MEFs (Fig. 4, A and C), whereas 
the expression of other tensins (tensins1 and 2) and of the 
known integrin activity regulators, talin, kindlin, ICAP1, fila-
min A, and SHA RPIN, remained unchanged (Fig. 4, A and C). 
In TIFs, the silencing of AMPK promoted tensin1 and tensin2 
protein expression with no alterations in tensin3, talin, kindlin, 
filamin A, or SHA RPIN expression levels (Fig.  4, B and C). 
In accordance with changes in protein expression, the mRNA 
levels of tensin3 in AMPK KO MEFs (Fig. 4 D) and tensin1 in 
siAMPK TIFs (Fig. 4 E) were significantly increased compared 
with the respective control cells. These data suggest that AMPK 
regulates the expression of fibrillar adhesion–associated tensins 
in an isoform- and cell type–dependent manner.
Tensin1 binds the membrane-proximal talin-binding 
NPxY motif of β-integrin tails through its PTB domain (Mc-
Cleverty et al., 2007). Nevertheless, the ability of tensin to regu-
late integrin inside-out activation has not been investigated thus 
far. To address whether tensins regulate integrin activity down-
stream of AMPK, we silenced tensin1 (siTensin1) or tensin3 
(siTensin3) in AMPK KO MEFs (Fig. S4 A) or AMPK-silenced 
TIFs (Fig. S4 B), and we observed a significant reduction in 
integrin activity upon the silencing of either tensin isoform 
in both cell types. Combined silencing of tensin1 and tensin3 
(siTensins1 and 3) decreased integrin activity in AMPK KO 
MEFs even further than the depletion of the individual tensins 
(Fig. S4 A), suggesting overlapping functions for tensin1 and 
tensin3 in the regulation of integrin activity. With this in mind, 
we decided to proceed with combined tensin1 and 3 silencing in 
the following experiments. Combined tensin silencing (siTen-
sin) induced a significant reduction in integrin activity in both 
WT and KO MEFs and, importantly, abolished any difference 
in integrin activity levels between these cells (Fig.  4  F). Re-
introduction of human tensin1 (GFP-TNS1) or human tensin3 
(GFP-TNS3) in tensin-silenced AMPK KO MEFs was able to 
rescue the decrease in integrin activity, and thus the observed 
effect of tensin siRNAs on integrin activity was not caused by 
off-target effects (Fig. 4 G). Importantly, overexpression of ten-
sin1 (GFP-TNS1) and, more prominently, tensin3 (GFP-TNS3) 
significantly increased integrin activity in TIFs (Fig. 4 H) and 
MEFs (Fig. S4 C), whereas overexpression of the focal adhe-
sion-specific tensin2 did not affect integrin activity in either 
TIFs or MEFs (Figs. 4 H and S4 C). Collectively, these data 
demonstrate that tensin1 and tensin3 support β1-integrin activ-
ity with possible overlapping and redundant roles.
Direct binding of tensin1 to the β1-integrin tail has been 
demonstrated previously, and amino acids essential for this 
interaction have been identified (McCleverty et al., 2007). In 
particular, alanine (A) substitution of proline P1624 in human 
tensin1 (GFP-TNS1P1624A) disrupts the tensin1–integrin inter-
action and the centripetal movement of α5β1-integrin (Rain-
ero et al., 2015). To address whether tensin3, the most potent 
tensin in supporting integrin activity, also regulates integrins 
through direct binding to the β1-integrin tail, we generated a 
point mutation in the PTB domain of tensin3. Based on homol-
ogy modeling using the established human tensin1 PTB do-
main (McCleverty et al., 2007), we identified histidine H1327 
in the human tensin3 PTB domain as corresponding to P1624 
in tensin1 (Fig. 4 I). Based on these analyses, we generated a 
human tensin3 mutant (GFP-TNS3H1327A), which demonstrated 
clearly reduced binding to active β1-integrin when compared 
with tensin3 WT (Fig. S4 D). To assess whether tensin-medi-
ated integrin activation depends on an intact tensin–integrin 
association, we overexpressed the binding-defective variants 
GFP-TNS1P1624A and GFP-TNS3H1327A in TIFs silenced for 
endogenous tensins (siTensin), which are known to form di-
mers (Lo et al., 1994a). Although GFP-TNS1 and GFP-TNS3 
significantly increased integrin activity in the absence of en-
dogenous tensins, GFP-TNS1P1624A was unable to increase 
integrin activity, and GFP-TNS3H1327A had a very small effect 
compared with GFP (Fig. 4 J). Collectively, the loss of AMPK 
promotes the transcriptional activation of the cytoskeletal pro-
teins tensin1 and tensin3, which bind to β1-integrin and sup-
port receptor activation.
Next, we investigated whether the ability of tensin to pro-
mote integrin activity is independent of talin. To address this 
question, we overexpressed GFP-TNS3 in the absence of talin1 
(siTalin1) and observed that tensin3 could only modestly en-
hance integrin activity (Fig. 4 K). Based on these data, we hy-
pothesize that integrin activity is triggered by talin1 in focal 
adhesions and subsequently maintained by tensins in fibrillar 
adhesions, where talin is mostly absent.
Figure 4. Tensin regulates integrin activity downstream of AMPK. (A–C) Immunoblotting (A and B) and quantification (C) of the indicated proteins in WT 
and AMPK KO MEFs (A and C) and siCtrl or siAMPK TIFs (B and C). GAP DH was used as a loading control. (D and E) Quantification of mRNA levels of 
Tns1 and Tns3 in AMPK WT and KO MEFs relative to the housekeeping genes Gapdh, TNS1, and TNS3 in siCtrl and siAMPK TIFs relative to the housekeep-
ing gene GAP DH (E). Data are expressed relative to WT (D) and siCtrl (E), respectively, and represent means ± SEM. ***, P < 0.0001 (two-tailed Student’s 
t test). (F–H) Quantification of flow cytometric assays of β1-integrin activity assessed as FN7–10 fragment binding relative to total β1-integrin in AMPK WT 
and KO MEFs (F), AMPK KO MEFs (G), or TIFs (H). (F) AMPK WT and KO MEFs silenced with control siRNA (siCtrl) or with siRNAs against tensin1 and 
tensin3 (siTensin). Data are expressed relative to WT siCtrl and represent means ± SEM. ***, P < 0.0001 for siTensin WT relative to siCtrl WT; *, P = 
0.0216 for siCtrl KO relative to siCtrl WT; and **, P < 0.0029 for siTensin KO relative to siCtrl KO (two-tailed Student’s t test). (G) siCtrl or siTensin AMPK 
KO MEFs transiently reexpressing GFP-TNS1, GFP-TNS3, GFP alone in AMPK KO MEFs. Data are expressed relative to siCtrl-GFP–expressing cells and 
represent means ± SEM. ***, P = 0.0002 for siTensin-GFP relative to siCtrl-GFP; *, P = 0.0399 for siCtrl-TNS1 relative to siCtrl-GFP; ***, P = 0.0006 for 
siCtrl-GFP-TNS3 relative to siCtrl-GFP; ***, P < 0.0001 for siTensin-GFP-TNS1 relative to siTensin-GFP; and **, P = 0.0019 for siTensin-GFP-TNS3 relative 
to siTensin-GFP (two-tailed Student’s t test). (H) TIFs transiently expressing GFP, GFP-TNS1, GFP-TNS2, or GFP-TNS3. Data are expressed relative to GFP and 
represent means ± SEM. **, P = 0.007 for GFP-TNS1 relative to GFP; and *, P < 0.03 for GFP-TNS3 relative to GFP (two-tailed Student’s t test). (I) Align-
ment of the tensin1 PTB domain (1606–1738; Protein Data Bank ID: 1WVH) with the predicted structure of the tensin3 PTB domain. The critical residues 
for binding β1-integrin are highlighted (yellow for tensin1 and red for tensin3). The amino acids P1624 in tensin1 and H1327 in tensin3 are indicated. (J 
and K) Quantification of flow cytometric assays of β1-integrin activity assessed as FN7–10 fragment binding relative to total β1-integrin in TIFs. (J) siCtrl or 
siTensin TIFs transiently expressing GFP, GFP-TNS1, point mutant GFP-TNS1P1624A, GFP-TNS3, and point mutant GFP-TNS3H1327A. Data are expressed rela-
tive to siCtrl GFP and represent means ± SEM. For siCtrl cells, *, P = 0.02 for GFP-TNS1 relative to GFP; ***, P < 0.0001 for GFP-TNS3 relative to GFP; 
***, P < 0.0001 for GFP-TNS3H1327A relative to GFP; and **, P = 0.004 for GFP-TNS3H1327A relative to GFP-TNS3. For siTensin cells, ***, P = 0.0004 
for GFP-TNS1 relative to GFP; ***, P < 0.0001 for GFP-TNS3 relative to GFP; ***, P < 0.0001 for GFP-TNS3H1327A relative to GFP; and **, P = 0.004 
for GFP-TNS3H1327A relative to GFP-TNS3. (K) Control or talin1-silenced (siTalin1) TIFs transiently expressing GFP or GFP-TNS3. Data are expressed relative 
to siCtrl GFP and represent means ± SEM. ***, P = 0.0002 for siCtrl GFP-TNS3 relative to siCtrl GFP; **, P = 0.0013 for siTalin GFP-TNS3 relative to 
siCtrl GFP-TNS3; *, P = 0.024 for siTalin GFP-TNS3 relative to siTalin GFP (two-tailed Student’s t test). Below are immunoblots assessing talin expression.
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Tensin regulates cell spreading, 
mechanotransduction, and fibrillogenesis 
downstream of AMPK
We further sought to explore whether tensin regulates the 
aforementioned integrin-dependent cellular functions down-
stream of AMPK. Indeed, tensin1 and tensin3 silencing (siTen-
sin) reduced the amount and the central distribution of active 
β1-integrin in AMPK KO MEFs plated on fibronectin-coated 
crossbow-shaped micropatterns (Fig.  5  A). In addition, ten-
sin silencing (siTensin) significantly reduced the spreading of 
AMPK KO MEFs plated on fibronectin (Fig.  5  B). Finally, 
tensin silencing reduced both the mechanical stress exerted 
by AMPK KO MEFs and the remodeling of fibronectin fibers 
as compared with control-silenced cells (Fig. 5, C and D). To 
conclude, tensins act downstream of AMPK to regulate integrin 
activity and localization, cell spreading, mechanotransduction, 
and fibronectin fibrillogenesis.
Discussion
AMPK is a critical metabolic sensor in cells maintaining energy 
homeostasis. In recent years, an increasing number of studies 
demonstrate that AMPK regulates several other cellular func-
tions, such as cell growth and transcription (Mihaylova and 
Shaw, 2011), cell polarity and cytoskeletal rearrangement (Mir-
ouse and Billaud, 2011), and mitosis (Banko et al., 2011). In 
this study, starting with unbiased screens (Rantala et al., 2011; 
Pellinen et al., 2012), we identified AMPK as an integrin ac-
tivity inhibitor through its ability to negatively regulate the ex-
pression of the integrin-binding proteins, tensins. Congruently, 
loss of AMPK promotes cell adhesion, mechanotransduction, 
and matrix assembly in fibroblasts (Fig. 6).
Integrin activation by talins and kindlins has been studied 
extensively; however, the role of other integrin-binding proteins 
in regulating integrin activity remains elusive. Our data demon-
strate that the scaffold protein tensin, known to bind β-integrin 
at one of the talin-binding sites, supports β1-integrin activity. 
This is unprecedented, given that other integrin-binding pro-
teins, like DOK-1, which has overlapping binding sites with 
talin, act as inhibitors of integrin activity (Calderwood et al., 
2013). A potential explanation for this finding is that tensins, 
similar to talin, are among the few proteins that couple integrins 
to actin (Lo et al., 1994b; Horton et al., 2016), and thus the 
integrin–tensin complex could extend the list of molecules me-
diating mechanosensitive coupling of active integrins to actin 
beyond the well-established integrin-talin-vinculin adhesions.
Fibroblasts adhering to fibronectin generate different 
types of adhesions, such as nascent, focal, and fibrillar ad-
hesions (Geiger and Yamada, 2011). The first newly formed 
nascent adhesions transform into focal adhesions and further 
into fibrillar adhesions under a maturation process that in-
volves force (Geiger and Yamada, 2011). Talins and kindlins 
are generally absent from fibrillar adhesions, whereas we and 
others (Clark et al., 2005) have observed high levels of ac-
tive β1-integrin localizing to these sites. It has been hypoth-
esized earlier—but never shown—that tensin would replace 
talin in fibrillar adhesions to maintain integrins in an active 
state (Pylayeva and Giancotti, 2007). Interestingly, we find 
that tensins induce integrin activity only in conjunction with 
talin. This suggests that in cells, active integrins may transit 
from a talin-bound active state to a tensin-maintained active 
form localizing in fibrillar adhesions. Thus, in this study, we 
provide concrete evidence for the ability of tensin to support 
β1-integrin activity, in accordance with the hypothesis of 
a “talin–tensin switch.”
Previous work has demonstrated a critical role for tensins 
in integrin turnover specifically from fibrillar adhesions (Rain-
ero et al., 2015) and has suggested that integrin and ECM uptake 
function to provide nutrients under starvation. It is likely that the 
level of active integrins in fibrillar adhesions is coupled to their 
endocytic uptake, but the details of this balance and its links 
to the metabolic state of the cell remain to be explored further.
Integrin adhesion complexes link the ECM to the actin 
cytoskeleton and mediate force transmission and signaling 
(Geiger et al., 2001), and thus integrin activity influences the 
mechanobiology of cells as well. Cell mechanics play a crucial 
role in cellular functions during development and disease. In 
this study, we correlate the loss of AMPK with a stiffening of 
the intracellular environment in agreement with previous work 
linking β1-integrin levels to the intracellular mechanical state 
(Baker et al., 2009). Mechanotransduction from the plasma 
membrane to the cell interior could be mediated by the actin 
cytoskeleton (Guet et al., 2014; Mandal et al., 2016), which is 
strongly reorganized upon the loss of AMPK (Fig. 1 D).
An open question remains on how AMPK regulates ten-
sin expression. AMPK is known to directly phosphorylate, 
and mostly negatively regulate, several transcription factors 
(Mihaylova and Shaw, 2011). Recently, it was suggested that 
AMPK can also regulate an array of miRNAs (Liu et al., 2013). 
Thus, one possibility is that in the absence of AMPK, the tran-
scription factor would translocate to the nucleus and promote 
tensin expression. Alternatively, an AMPK-regulated miRNA 
could inhibit tensin expression in cells.
Initially, it might seem paradoxical that a lack of AMPK, 
a central metabolic regulator, could trigger energy-demanding 
functions such as matrix remodeling and mechanotransduction. 
However, the loss of AMPK promotes increased glycolysis 
(Faubert et al., 2013) to generate ATP and to fuel biosynthesis, 
and therefore AMPK-deficient fibroblasts are not under energy 
stress. Interestingly, quiescent fibroblasts, the primary cells that 
build and maintain the ECM in most soft connective tissues 
(Humphrey et al., 2014), have increased glycolytic (metabolic) 
activity associated with enhanced ECM formation (Lemons et 
al., 2010; Suh et al., 2012).
Fibrillar adhesions are critically important to the most 
relevant function of fibroblasts in vivo: ECM generation and 
remodeling. Excessive production of ECM proteins by fibro-
blasts is linked to many severe human fibrotic conditions, such 
as chronic kidney disease (Chen et al., 2014a), cardiac hypertro-
phy (Pelouch et al., 1993), and liver fibrosis (Lim et al., 2012). 
Recently, AMPK activation has been shown to ameliorate fibro-
sis in several tissues, and AMPK activators have been suggested 
as potential therapeutics in the treatment of the aforementioned 
diseases (Beauloye et al., 2011; Satriano et al., 2013). Our data 
demonstrating that AMPK inhibition induces fibrillar adhe-
sions, integrin activity, and the ability of fibroblasts to modify 
ECM composition via fibronectin fibrillogenesis provide im-
portant mechanistic insight into the link between AMPK and 
fibrosis. Currently, the clinical relevance of tensins in fibrotic 
conditions linked to AMPK activity is not known, and this will 
be an interesting area of research in the future.
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Figure 5. Tensin regulates cell spreading, mechanotransduction, and fibrillogenesis downstream of AMPK. (A) Representative mean intensity maps of 
bottom-plane images obtained with a spinning-disk confocal microscope. siCtrl or siTensin AMPK KO MEFs are stained for active β1-integrin (9EG7) and 
plated on fibronectin-coated crossbow-shaped micropatterns. The mean active β1-integrin distribution is represented with a heat map, wherein yellow cor-
responds to regions within the cell containing the largest accumulation of active β1-integrin. The white ovals indicate the centrally located adhesions, and 
the level of active β1-integrin within the ovals was quantified and displayed as Tukey box plots. n > 70 cells from four biological repeats. (B) Adherence of 
siCtrl and siTensin AMPK KO MEFs on fibronectin (1 µg/ml) as measured in real time using the xCELLigence RTCA instrument. Quantification of relative cell 
adhesion (cell index) at 2 h after plating is shown. Data are expressed relative to siCtrl and represent means ± SEM. n > 35 from 12 independent experi-
ments. (C) Representative traction force maps and quantification of the mean force (strain energy, pJ) exerted by siCtrl and siTensin AMPK KO MEFs plated 
on fibronectin-coated (5 µg/ml) polyacrylamide gels with a Young’s modulus of ∼3 kPa. Black arrows indicate the direction of traction stress. Cell contours 
are denoted by white lines. The color code gives the magnitude of traction stress in Pa, which corresponds to forces of pN/µm2. Data are displayed as 
Tukey box plots. n = 18–19 cells from three biological repeats. (D) Representative confocal images obtained with a spinning-disk confocal microscope 
and quantification of the area covered by fibronectin in siCtrl and siTensin AMPK KO MEFs 16 h after supplementation with 10 µg/ml fibronectin. Data 
are displayed as Tukey box plots. n > 70 images from three biological repeats. (A, C, and D) Bars: (A and C) 10 µm; (D) 20 µm. (A–D) ***, P < 0.0001 
(two-tailed Student’s t test).
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Materials and methods
MEF isolation and cell culture
To generate immortalized MEFs, pregnant female mice were main-
tained in the University of Helsinki’s Laboratory Animal Center, and 
MEF isolation was approved by the National Animal Experiment 
Board in Finland. AMPKα1+/−;α2lox/lox and AMPKα1−/−;α2lox/lox MEFs 
were isolated from E12.5 embryos and immortalized at passage 2 
using the carboxy terminus of p53 in pBabe-Hygro57 and 200 mg/
ml hygromycin selection for 7 d (Yan et al., 2015). MEFs were then 
transduced with adenoviral vectors expressing GFP to obtain immor-
talized AMPKα1+/−;α2+/+ (WT) and AMPKα1−/−;α2+/+ (α1KO) or Cre 
recombinase to obtain immortalized AMPKα1+/−;α2−/− (α2KO) and 
AMPKα1−/−;α2−/− (KO) MEFs. MEFs were cultured in DMEM 4500 
(Sigma-Aldrich) supplemented with 10% FBS (Gibco), 2 mM l-glu-
tamine (Sigma-Aldrich), and 1 mM pyruvate. Human TIFs were a gift 
from J. Norman (Beatson Institute, Glasgow, Scotland, UK) and were 
cultured in DMEM 4500 supplemented with 20% FBS, 2 mM l-gluta-
mine, and 20 mM Hepes buffer (Sigma-Aldrich). HEK293 cells were 
grown in DMEM 4500 supplemented with 10% FBS and 2 mM l-glu-
tamine. All cells were routinely tested for mycoplasma contamination.
siRNA and plasmid transfections
siRNA silencing was performed using 20 nM siRNA oligonucleotides 
and Lipofectamine RNAiMAX reagent (Thermo Fisher Scientific) 
according to the manufacturer’s protocol, and cells were cultured for 
3 d.  The siRNAs used for simultaneous AMPKα1 and AMPKα2 si-
lencing were PRK AA1 (sc-29673), PRK AA2 (sc-38923), and con-
trol (sc-37007; Santa Cruz Biotechnology, Inc.; Wang et al., 2012). 
The additional siRNAs against AMPKα1 were from Integrated DNA 
Technologies (siRNA 1: 151509037; and siRNA 2: 151509031). The 
siRNAs against mouse Prkaa1 (L-041035; smartpool), mouse Prkaa2 
(L-040809; smartpool), mouse Tns1 (L-040925; smartpool), mouse 
Tns3 (L-063982; smartpool; and J-063982-08; individual), human ten-
sin1 (L-009976; smartpool), human tensin3 (L-009997; smartpool), 
and control (D-001810-10; nontargeting pool) were ON-TAR GETplus 
siRNAs from Thermo Fisher Scientific. The siRNA against human talin1 
was Hs_TLN1_2 FlexiTube (SI00086968), and the negative control 
used was the AllStars Negative Control (SI03650318) from QIA GEN. 
Sequences of all the siRNAs used are provided in the Table S1. Lipo-
fectamine 3000 and P3000TM Enhancer reagent (Thermo Fisher Sci-
entific) were used for transient plasmid transfections according to the 
manufacturer’s protocol, and the cells were cultured for 24 h. Transient 
overexpressions in previously silenced cells were performed 72–96 h 
after siRNA transfection, when the endogenous tensin protein levels 
were still reduced but no effective siRNA was present anymore.
GFP-TNS1 and GFP-TNS3 constructs were generated by insert-
ing SalI-digested sequences into pEGFP-C1 vectors cut with XhoI and 
HindIII enzymes (Takara Bio Inc.; Clark et al., 2010). GFP-TNS1P1624A 
was a gift from J. Norman. GFP-TNS3-H1327→A site-directed point 
mutation was introduced using the QuikChange II XL Site-directed 
Mutagenesis kit (Agilent Technologies) according to the manufactur-
er’s instructions. The primers used were forward, 5′-CCC TCA CCG 
GCG CCC AGG CGA TCC AGA AGG CCC-3′, and reverse, 5′-CCT TCT 
GGA TCG CCT GGG CGC CGG TGA GGG ACT CC-3′. All constructs 
were validated with sequencing.
Antibodies, compounds, and reagents
The following antibodies were used in the study: rabbit (rbt) anti–phos-
phorylated acetyl-CoA carboxylase (ACC; 3662), rbt anti-ACC (3661), 
rbt anti-AMPK (2532), rbt anti–filamin A (4762; Cell Signaling Tech-
nology), rbt anti-tensin1 (Sab4200283), rbt anti-tensin2 (SAB4200161), 
rbt anti-fibronectin (F3648), mouse (ms) anti-talin1 (clone 8d4; T3287; 
Sigma-Aldrich), rbt anti-tensin3 (Rb33; gift from K. Clark, University 
of Leicester, Leicester, England, UK; Clark et al., 2010), rbt anti–β1- 
integrin tail (clone EP1041Y; Ab52971), ms anti–human active β1-inte-
grin (clone 12G10; Ab30394), rbt anti-kindlin (ab68041), ms anti-GFP 
(clone 9F9.F9; Ab1218; Abcam), rat anti–mouse active β1-integrin 
(clone 9EG7; 553715; BD), rat anti–mouse total β1-integrin (clone 
MB1.2; MAB1997; EMD Millipore), ms anti–human total β1-integrin 
(clone P5D2; Developmental Studies Hybridoma Bank), rbt anti-paxil-
lin (H114; sc5574; Santa Cruz Biotechnology, Inc.), rbt anti-SHA RPIN 
Figure 6. Model showing how AMPK loss promotes tensin-mediated integrin activity. In the absence of AMPK, the transcriptional constraints that limit ten-
sin expression are removed. A corresponding increase in tensin expression leads to enhanced tensin binding to β1-integrin tails to support integrin activity 
after initial integrin activation by talin. This leads to enhanced fibrillar adhesion formation and integrin-dependent processes such as mechanotransduction 
and fibronectin remodeling. P, phosphorylated.
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(bs-9581R; Bioss Inc.), ms anti–human active α5-integrin (SNA KA51; 
gift from M. Humphries, University of Manchester, Manchester, En-
gland, UK; Clark et al., 2005), rbt anti-ICAP1 (gift from D. Bouvard, 
Centre National de la Recherche Scientifique, Paris, France), and ms 
anti-GAP DH (5G4; Mab6C5; HyTest). Phalloidin Atto 647N (65906) 
was obtained from Sigma-Aldrich. Alexa Fluor–conjugated secondary 
antibodies (Alexa Fluor 488–, 555–, and 647–conjugated anti–mouse, 
–rabbit, and –rat antibodies; Thermo Fisher Scientific) were used in 
immunofluorescence and flow cytometry. Bovine plasma fibronec-
tin (341631) was purchased from EMD Millipore, and dorsomorphin 
(S7306; dissolved in DMSO) was obtained from Selleckchem.
Western blot
Protein extracts were separated using SDS-PAGE under denaturing 
conditions (4–20% Mini-PRO TEAN TGX Gels) and were transferred 
to the nitrocellulose membrane (Bio-Rad Laboratories). Membranes 
were blocked with 5% milk-TBST (Tris-buffered saline and 0.1% 
Tween 20), incubated with the indicated primary antibodies overnight 
at 4°C, and then incubated with fluorophore-conjugated or ECL HRP-
linked secondary antibodies (GE Healthcare) at RT for 1 h. Membranes 
were scanned using an infrared imaging system (Odyssey; LI-COR 
Biosciences) or ECL Plus Western blotting reagent (GE Healthcare), 
and film was developed. Band intensity was determined using Fiji (Im-
ageJ; National Institutes of Health; Schindelin et al., 2012).
Flow cytometry assays for β1-integrin activity
For the flow cytometry assay using labeled FN7–10 binding as a read-
out of cell surface active β1-integrin levels, cells were detached using 
trypsin, washed once with full medium containing 10% FBS, and re-
suspended in 100  µl of 37°C serum-free medium with (a) 10 µg/ml 
Alexa Fluor 647–conjugated FN7–10, (b) 30 µg/ml FN7–10 supple-
mented with 5 mM EDTA (the negative control), or (c) total β1-integrin 
antibody (P5D2 for human cells or 10 µg/ml MB1.2 for mouse cells) 
and 10 µg/ml Alexa Fluor 647–conjugated secondary antibody. Cells 
were incubated with rotation for 45 min at RT. After washing once with 
cold Tyrode’s buffer (10 mM Hepes-NaOH, pH 7.5, 137 mM NaCl, 
2.68 mM KCl, 0.42 mM NaH2PO4, 1.7 mM MgCl2, 11.9 mM NaHCO3, 
5 mM glucose, and 0.1% BSA), cells were fixed with 4% PFA in PBS 
for 10 min at RT, and fluorescence was measured by flow cytometry 
(FAC SCalibur, LSRFortessa, or LSR II; BD). The Geomean fluorescent 
intensity was measured from 5,000–20,000 events. Viable single cells 
were gated by forward scatter and side scatter dot blots (2.5.1; Flowing 
Software). In experiments using GFP constructs, the GFP-expressing 
cells were gated and analyzed for allophycocyanin (647) intensity. 
Flow cytometric analysis of active β1-integrin cell surface levels using 
conformation-specific antibodies was performed in PFA-fixed cells. 
Cells were washed with cold Tyrode’s buffer and stained with active 
β1-integrin specific antibody (5 µg/ml 9EG7 for human/mouse cells) 
or total β1-integrin antibody (P5D2 for human and MB1.2 for mouse 
cells) for 1 h at 4°C (Nevo et al., 2010). Cells were washed with Ty-
rode’s buffer and incubated with fluorescently conjugated secondary 
antibodies (6 µg/ml) for 1 h at 4°C. The negative control cells were 
stained only with secondary antibody. All antibodies were diluted into 
Tyrode’s buffer. Fluorescence was measured by flow cytometry (FAC 
SCalibur or LSRFortessa).
Adhesion assay using xCELLigence real-time cell analysis (RTCA)
The xCELLigence RTCA instrument (Roche) was used to measure cell 
adhesion over time. RTCA measures impedance between electrodes 
(bottom sensors) expressed as cell index values. The 96-well E-plate 
(Roche) was coated with 1 µg/ml fibronectin or 5 µg/ml vitronectin 
(A14700; Thermo Fisher Scientific) in PBS, followed by blocking 
with 0.1% BSA in PBS, both at 37°C for 1  h.  The cells were de-
tached and washed with full medium containing 10% FBS, and 10,000 
cells/well were seeded on E-plates in serum-free medium. Cell index 
was measured in real time.
Fibronectin fibrillogenesis
50,000 cells were plated on coverslips and allowed to adhere for 
4 h. After the addition of exogenous 10 µg/ml fibronectin, cells were 
incubated for a further 16 h and then fixed with 4% PFA. Cells were 
stained with anti-fibronectin (5 µg/ml), phalloidin (1:200), and DAPI 
(0.5 µg/ml; nuclei staining) in PBS. The length of individual fibers was 
determined manually in ImageJ. To assess fibronectin coverage, the 
images were processed with fast Fourier transform bandpass filters to 
visualize all fibers, and the amount of fibronectin was measured by 
thresholding using Fiji (Schindelin et al., 2012).
Microscopy
Confocal images were acquired with a spinning-disk confocal micro-
scope (Marianas spinning-disk imaging system [Intelligent Imaging 
Innovations, Inc.] with a CSU-W1 scanning unit [Yokogawa Electric 
Corporation] on an inverted Axio Observer Z1 microscope [ZEI SS]) 
using a 63×, 1.4 N.A. Oil Plan-Apochromat M27 with a differential in-
terference contrast III Prism or a 100×, 1.4 N.A. Oil Plan-Apochromat 
M27 objective and an Orca Flash 4 sCMOS camera (Hamamatsu Pho-
tonics), and software used was Slidebook 6 (Intelligent Imaging Innova-
tions, Inc.). Fixed samples were mounted with Mowiol 4–88 (475904; 
EMD Millipore) containing 2.5% 1,4-diazobicyclo-[2.2.2]-octane 
(D27802; Sigma-Aldrich) and imaged at RT. The fluorescence intensity 
and the coverage of the antibody staining were quantified by threshold-
ing using Fiji and normalized to cell area.
Images with a TIRF microscope (Laser-TIRF 3 Imaging Sys-
tem; ZEI SS) were acquired using a 63×, 1.46 N.A. Oil α Plan-Apo-
chromat differential interference contrast or a 100×, 1.46 N.A. Oil α 
Plan-Apochromat differential interference contrast objective and an 
electron-multiplying charge-coupled device camera (ImageEM C9100-
13; Chip size, 512 × 512; Hamamatsu Photonics) controlled by the Zen 
software (Zen 2012 Blue Edition Systems; ZEI SS). Fixed TIRF sam-
ples were kept in PBS during imaging and were imaged at RT. Quanti-
tative analysis for images was performed using Fiji.
Micropatterns and immunostaining
Micropatterns were produced on glass coverslips (Azioune et al., 
2009; Alanko et al., 2015). Glass coverslips were cleaned with 97% 
ethanol, dried with airflow, and exposed to deep UV light for 5 min. 
The clean coverslips were placed upside down on parafilm containing 
0.1 mg/ml poly(l-lysine)-graft-poly(ethylene glycol) (Surface Solu-
tions) in 10 mM Hepes, pH 7.3, and incubated for 1 h at RT. They were 
then rinsed once with PBS and once with water, dried, and stored on the 
bench. Crossbow-shaped 45-µm micropatterns were designed on a chro-
mium synthetic quartz photomask (Delta Mask B.V.). The photomask 
was cleaned once with water and twice with 97% ethanol, dried with air-
flow, and exposed to deep UV light for 5 min. Small drops of water were 
pipetted on the clean photomask, and the pegylated coverslips were 
placed on top. The photomask with the coverslips facing down were 
placed in the UV oven for 6 min. The coverslips were removed from 
the photomask with water, dried, and coated with 50 µg/ml fibronectin 
and 5 µg/ml fibrinogen Alexa Fluor 647 for 1 h at RT. The coverslips 
were placed in 12-well plates and incubated with medium without anti-
biotics containing 20 mM Hepes at 37°C for 5 min. The cells were then 
trypsinized, and 100,000 cells were plated, left to adhere for 10 min at 
37°C, washed with medium to remove nonadherent cells, and incubated 
for another 7 h in culture medium containing Hepes before fixing with 
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4% PFA. Alternatively, cells were plated on 5 µg/ml fibronectin–coated 
glass-bottom dishes (MatTek Corporation) for 7 h and fixed with 4% 
PFA. Samples were washed, permeabilized with 0.5% Triton-X for 
10 min, blocked with 1 M glycine for 30 min, washed, and incubated 
with the indicated primary antibodies for another 30 min. After further 
washes, cells were incubated with Alexa Fluor–conjugated secondary 
antibodies (6 µg/ml), 647N-phallodin (1:200), and 0.5 µg/ml DAPI in 
PBS for 30 min. For Mn2+ treatment, adherent cells were incubated for 
2 h with 2 mM Mn2+ before fixation. Finally, cells were washed and 
imaged with a TIRF or spinning-disk confocal microscope.
Traction force microscopy (TFM)
Preparation of hydrogels. Glass coverslips (P35G-1.0-14-C; MatTek 
Corporation) were treated with 100 µl Bind Silane solution (a mixture 
of 714 µl PlusOne Bind Silane [Silane A-174; GE Healthcare], 714 µl 
acetic acid, and 96% ethanol [≤10 ml]) for 10 min at RT. The glass 
was washed twice with ethanol and once with mQH2O and was left 
to dry completely. A mixture of 150  µl of 40% acrylamide (A4058; 
Sigma-Aldrich), 50 µl of 2% N, N′-methylenebisacrylamide solution 
(M1533; Sigma-Aldrich), 300 µl PBS, and 3.4 µl of sonicated 0.2-µm 
FluoroSphere beads (505/515; F881; Thermo Fisher Scientific) was 
preprepared and vortexed briefly. Gel polymerization was initiated 
by the addition of 1 µl of Temed (T9281; Sigma-Aldrich) and 5 µl of 
10% ammonium persulfate to the acrylamide mix. After quick vortex-
ing, 11.7 µl of this mixture was pipetted onto the glass plates, a round 
13-mm coverslip was carefully placed on top of the drop so that a thin 
layer of liquid remained between the two glass surfaces, and the mix-
ture was incubated for 1  h.  PBS was then added to cover the entire 
dish, and the glass coverslip was carefully removed. This protocol of 
hydrogel preparation achieved a Young’s modulus of ∼3 kPa. For func-
tionalization, 0.2 mg/ml sulfo-SAN PAH (22589; Thermo Fisher Sci-
entific) and 2 mg/ml N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC; 03450; Sigma Aldrich) in 50  mM Hepes were 
added on top of formed gels and incubated for 30 min at RT with gentle 
agitation. Gels were put into a UV chamber for 10 min without cover to 
activate the sulfo-SAN PAH and finally were washed three times with 
PBS before overnight coating with fibronectin at 4°C.
Image acquisition and TFM analysis. Cells were plated onto 
TFM plates 24  h before the experiment. For imaging, we used an 
LSM780 laser-scanning confocal microscope and a 63×, 1.2 W C Apo-
chromat objective (ZEI SS). The cells were maintained in their culture 
medium during imaging and were imaged live at 37°C. A fluorescence 
image of the beads (Excitation, 488 nm; Detection, 500–550 nm) and a 
phase-contrast image of the colonies were recorded for 7–10 colonies 
per sample. To ensure good-quality imaging of fluorescent beads, we 
performed Z stacks of 11 images with a separation of 1 µm and then 
manually chose the best focus. After the first round of images, cells 
were removed by the addition of an extraction buffer (20 mM NH4OH 
and 0.5% Triton-X in PBS). At this point, reference images for each of 
the 7–10 locations, now without cells, were recorded in the exact same 
way as images acquired with the cells. To extract the bead displacement 
fields, we used a MAT LAB software package (MathWorks) provided 
by T. Betz (University of Münster, Münster, Germany) that uses a cor-
relation algorithm described previously (Betz et al., 2011). Traction 
forces were determined using the same MAT LAB software package 
after the Fourier transform traction force algorithm, as introduced by 
Butler et al. (2002).
Microrheology in micropatterned cells
Active microrheology based on optical tweezers was performed in 
crossbow-shaped micropatterned cells (Guet et al., 2014; Mandal et 
al., 2016). In brief, 2-µm-diameter fluorescent microspheres (Thermo 
Fisher Scientific) were allowed to internalize in cells overnight. Cells 
were then detached and allowed to readhere for 2 h on 38-µm-diam-
eter crossbow-shaped micropatterns coated with 5 µg/ml fibronectin. 
The culture medium was supplemented with 20  mM Hepes before 
experimental manipulations on an A1R confocal microscope (Nikon) 
equipped with a 37°C incubator, a nanometric piezostage (Mad City 
Labs), and a homemade single fixed optical trap (1,060–1,100 nm; 2-W 
maximal output power; IPG Photonics). A bead was trapped by optical 
tweezers (1-W laser output power, corresponding to 150 mW on the 
sample), and after a 0.5-µm step displacement of the stage applied by 
the piezostage, the bead relaxation xb(t) toward the optical trap center 
was measured using single particle tracking. First, a model-indepen-
dent phenomenological parameter, the rigidity index, was calculated as 
the normalized area under the relaxation curve (Mandal et al., 2016). 
Second, the SLL model (Bausch et al., 1999; Chan et al., 2015; Man-
dal et al., 2016) was used to fit the relaxation curves. The SLL model 
consists of a Kelvin–Voigt body (a spring of spring constant μ and a 
dashpot of viscosity η in parallel) and a dashpot in series.
Quantitative real-time PCR
Total cellular RNA was extracted using the NucleoSpin RNA kit 
(MAC HER EY-NAG EL), and 1 µg of the extracted RNA was used as 
a template for cDNA synthesis by the high-capacity cDNA reverse 
transcription kit (Applied Biosystems) according to the manufacturer’s 
protocol. Expression levels of human and mouse Tensin1 and Tensin3 
were determined by TaqMan quantitative real-time PCR using the RT-
PCR HT7900 (Applied Biosystems). The expression level of GAP DH 
was used as a reference (endogenous control). TaqMan Universal Mas-
ter Mix II included necessary components for quantitative RT-PCR 
reactions. The following primers from Sigma-Aldrich were used for 
human samples: human TNS1 (forward, 5′-CCA GAC ACC CAC CTG 
ACT TAG-3′, and reverse, 5′-CAG CTC ATG GTT GGA TGGA-3′; Uni-
versal ProbeLibrary probe 82), human TNS3 (forward, 5′-AGG CTG 
CCT GAC ACA GGA-3′, and reverse, 5′-AGG GGC TGT TCA GCA 
GAG-3′; Universal ProbeLibrary probe 57), and human GAP DH (for-
ward, 5′-GCT CTC TGC TCC TCC TGT TC-3′, and reverse, 5′-ACG 
ACC AAA TCC GTT GAC TC-3′; probe 60). The following primers from 
Sigma-Aldrich were used for mouse samples: mouse Tns1 (forward, 
5′-GAC AAG ATC GTG CCC ATTG-3′, and reverse, 5′-CCA GAG AGT 
AGG CCA CTG AAG-3′; Universal ProbeLibrary probe 82) and mouse 
Tns3 (forward, 5′-TCC GTT CAG TCC ACC TGAG-3′, and reverse, 5′-
ATC TCT GGG CAG CCT CGT-3′; Universal ProbeLibrary probe 20); 
mouse Gapdh primers and probes were from Universal ProbeLibrary. 
Relative expression was calculated by the 2ΔΔCT method using the 
expression level of GAP DH as a reference for the quantification.
Immunoprecipitation
HEK293 cells were transiently transfected with expression constructs 
coding for pEGFP-C1, GFP-TNS3, and GFP-TNS3 with H1327A mu-
tation. Cells were lysed (0.5% Triton X-100, 10 mM Pipes, pH 6.8, 
150 mM NaCl, 150 mM sucrose, 3 mM MgCl2, cOmplete, and phos-
phatase inhibitors [Mediq; Roche]), cleared by centrifugation, and 
incubated with antibody-coated protein G magnetic beads (1 µg of an-
tibody per 10 µl of beads; Dynabeads; Thermo Fisher Scientific) for 
1 h at 4°C. Complexes bound to the beads were isolated using magnets, 
washed three times with ice-cold lysis buffer, and eluted in reducing 
sample buffer (Jacquemet et al., 2013). Input and precipitate samples 
were analyzed by Western blotting.
Homology modeling of TNS3 PTB domain
The TNS3-PTB domain (1309–1439) was modeled using a Swiss-
Model server and the TNS1-PTB domain (1606–1738; Protein Data 
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Bank ID: 1WVH) as a template. Then, pairwise structure superimpo-
sition of TNS3-PTB and TNS1-PTB was performed using Molecular 
Graphics Systems software (1.7.4.4 Edu; PyMOL).
Statistical analysis
Statistical significance was determined using the unpaired two-tailed 
Student’s t test unless otherwise indicated. All experiments were re-
peated at least three times unless otherwise indicated. Data distribution 
was assumed to be normal, but this was not formally tested. n numbers 
are indicated in the graphs as black dots or in the figure legends. A 
p-value of 0.05 was considered to be a borderline for statistical signif-
icance. P-values are indicated in the figure legends. Tukey box plots 
show the 25th–75th percentiles delineated by the upper and lower lim-
its of the box, the median is shown by the horizontal line inside the box, 
whiskers extend to data points that are >1.5× interquartile range away 
from first/third quartile, and outliers are represented by open circles.
Online supplemental material
Fig. S1 shows that AMPK negatively regulates β1-integrin activity. Fig. 
S2 shows that AMPK depletion promotes fibrillar adhesion formation. 
Fig. S3 shows that loss of AMPK enhances cell adhesion, fibrillogen-
esis, mechanotransduction, and intracellular stiffness. Fig. S4 shows 
that tensin regulates integrin activity downstream of AMPK. Table S1, 
included as an Excel file, is a list of siRNA sequences used in this study.
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